Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,667 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621.
Molina JR, Foster NR, Reungwetwattana T, Nelson GD, Grainger AV, Steen PD, Stella PJ, Marks R, Wright J, Adjei AA. Molina JR, et al. Among authors: marks r. Lung Cancer. 2014 Aug;85(2):245-50. doi: 10.1016/j.lungcan.2014.03.004. Epub 2014 May 1. Lung Cancer. 2014. PMID: 24957683 Free PMC article. Clinical Trial.
The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement.
Sawyer TE, Bonner JA, Gould PM, Foote RL, Deschamps C, Trastek VF, Pairolero PC, Allen MS, Shaw EG, Marks RS, Frytak S, Lange CM, Li H. Sawyer TE, et al. Among authors: marks rs. Cancer. 1997 Oct 15;80(8):1399-408. doi: 10.1002/(sici)1097-0142(19971015)80:8<1399::aid-cncr6>3.0.co;2-a. Cancer. 1997. PMID: 9338463
Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group.
Kirschling RJ, Grill JP, Marks RS, Kugler JW, Gerstner JB, Kuross SA, Michalak JC, Windschitl HE, Krewer KD, Jett JR. Kirschling RJ, et al. Among authors: marks rs. Am J Clin Oncol. 1999 Oct;22(5):517-22. doi: 10.1097/00000421-199910000-00019. Am J Clin Oncol. 1999. PMID: 10521070 Clinical Trial.
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma.
Bonner JA, Sloan JA, Shanahan TG, Brooks BJ, Marks RS, Krook JE, Gerstner JB, Maksymiuk A, Levitt R, Mailliard JA, Tazelaar HD, Hillman S, Jett JR. Bonner JA, et al. Among authors: marks rs. J Clin Oncol. 1999 Sep;17(9):2681-91. doi: 10.1200/JCO.1999.17.9.2681. J Clin Oncol. 1999. PMID: 10561342 Clinical Trial.
Chemotherapy for advanced CNS ependymoma.
Gornet MK, Buckner JC, Marks RS, Scheithauer BW, Erickson BJ. Gornet MK, et al. Among authors: marks rs. J Neurooncol. 1999;45(1):61-7. doi: 10.1023/a:1006394407245. J Neurooncol. 1999. PMID: 10728911
1,667 results